Shin Hisahara

Dr. Shin Hisahara

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2011 in International Journal of Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
SHShin Hisahara
Shin Hisahara
SSShun Shimohama
Shun Shimohama
Parkinson's disease (PD) is a progressive extrapyramidal motor disorder. Pathologically, this disease is characterized by the selective dopaminergic (DAergic) neuronal degeneration in the substantia nigra. Correcting the DA deficiency in PD with levodopa (L-dopa) significantly attenuates the motor symptoms; however, its effectiveness often declines, and L-dopa-related adverse effects emerge after long-term treatment. Nowadays, DA receptor agonists are useful medication even regarded as first choice to delay the starting of L-dopa therapy. In advanced stage of PD, they are also used as adjunct therapy together with L-dopa. DA receptor agonists act by stimulation of presynaptic and postsynaptic DA receptors. Despite the usefulness, they could be causative drugs for valvulopathy and nonmotor complication such as DA dysregulation syndrome (DDS). In this paper, physiological characteristics of DA receptor familyare discussed. We also discuss the validity, benefits, and specific adverse effects of pharmaceutical DA receptor agonist.

1 August 2003 in Neuroscience Research
Verified
Journal Article
Closed access
SHShin Hisahara
Shin Hisahara
HOHideyuki Okano
Hideyuki Okano
MMMasayuki Miura
Masayuki Miura

1 January 2011 in Parkinson's Disease
Verified
Journal Article
Open access
PDF file
SHShin Hisahara
Shin Hisahara
SSShun Shimohama
Shun Shimohama
Parkinson's disease (PD) is a common progressive neurodegenerative disorder. The major pathological hallmarks of PD are the selective loss of nigrostriatal dopaminergic neurons and the presence of intraneuronal aggregates termed Lewy bodies (LBs), but the pathophysiological mechanisms are not fully understood. Epidemiologically, environmental neurotoxins such as pesticides are promising candidates for causative factors of PD. Oxidative stress and mitochondrial dysfunction induced by these toxins could contribute to the progression of PD. While most cases of PD are sporadic, specific mutations in genes that cause familial forms of PD have led to provide new insights into its pathogenesis. This paper focuses on animal models of both toxin-induced and genetically determined PD that have provided significant insight for understanding this disease. We also discuss the validity, benefits, and limitations of representative models.

6 September 2016 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
TCthe Japan Multiple Sclerosis Genetics Consortium
the Japan Multiple Sclerosis Genetics Consortium
YNYuri Nakamura
Yuri Nakamura
TMTakuya Matsushita
Takuya Matsushita
SSShinya Sato
Shinya Sato
MNMasaaki Niino
Masaaki Niino
JKJun-ichi Kira
Jun-ichi Kira
Higher latitude and human leukocyte antigen (HLA)-DRB1*04:05 increase susceptibility to multiple sclerosis (MS) in the Japanese population, but their effects on disease severity are unknown. We aimed to clarify the effects of latitude and the HLA-DRB1 and HLA-DPB1 genes on disease severity in Japanese patients with MS. We enrolled 247 MS patients and 159 healthy controls (HCs) from the northernmost main island of Japan, Hokkaido Island (42–45° north), and 187 MS patients and 235 HCs from the southern half (33–35° north) of the Japanese archipelago (33–45° north). We genotyped HLA-DRB1 and HLA-DPB1 alleles, compared demographic features, and analyzed factors contributing to differences in clinical and laboratory findings between MS patients from southern and northern Japan. The Multiple Sclerosis Severity Score (MSSS), which adjusts the Kurtzke’s Expanded Disability Status Scale score according to disease duration, was used to estimate disease severity. The HLA-DRB1*04:05 and DRB1*15:01 alleles conferred susceptibility to MS in our Japanese population (p corr = 0.0004 and p corr = 0.0019, respectively). Southern patients had higher MSSS scores than northern patients (p = 0.003). Northern patients had higher frequencies of brain lesions meeting the Barkhof criteria (Barkhof brain lesions) and cerebrospinal fluid (CSF) IgG abnormalities than southern patients (p = 0.0012 and p < 0.0001, respectively). DRB1*04:05-positive MS patients had lower MSSS scores and lower frequencies of Barkhof brain lesions and CSF IgG abnormalities than DRB1*04:05-negative MS patients (p = 0.0415, p = 0.0026, and p < 0.0001, respectively). Multivariate analyses revealed that latitude and DRB1*04:05 were independently associated with the lowest quartile of MSSS and that latitude was positively associated with Barkhof brain lesions and CSF IgG abnormalities. DRB1*04:05 was negatively associated with these parameters. MSSS was decreased by 0.57 per DRB1*04:05 allele (p = 0.0198). Living at a higher latitude and carrying the DRB1*04:05 allele independently lessens MS symptom severity as defined by MSSS. However, these factors influence the frequency of Barkhof brain lesions and CSF IgG abnormalities in opposite ways; higher latitude increases the frequency of Barkhof brain lesions and CSF IgG abnormalities, whereas DRB1*04:05 decreases them.

12 March 2019 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
MFMai Fujikura
Mai Fujikura
NINaotoshi Iwahara
Naotoshi Iwahara
SHShin Hisahara
Shin Hisahara
JKJun Kawamata
Jun Kawamata
AMAkihiro Matsumura
Akihiro Matsumura
SSShun Shimohama
Shun Shimohama
We previously demonstrated that microglia play an essential role in clearance of amyloid-β (Aβ ) in Alzheimer’s disease (AD)-like pathology. Our prior work also showed that several receptors expressed on microglia participated in Aβ phagocytosis. How

1 March 2021 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SHShin Hisahara
Shin Hisahara
NINaotoshi Iwahara
Naotoshi Iwahara
TMTakashi Matsushita
Takashi Matsushita
SSSyuuichirou Suzuki
Syuuichirou Suzuki
AMAkihiro Matsumura
Akihiro Matsumura
SSShun Shimohama
Shun Shimohama